Evidence map›Paper›PMID 32472096›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2020

Deep learning shows the capability of high-level computer-aided diagnosis in malignant lymphoma.

Hiroaki Miyoshi, Kensaku Sato, Yoshinori Kabeya, Sho Yonezawa, Hiroki Nakano, Yusuke Takeuchi, Issei Ozawa, Shoichi Higo, Eriko Yanagida, Kyohei Yamada and 13 more

Abstract readValidation Study
PubMed Publisher
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 3 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 3 syntheses or guidelines pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. [Analysis of clinical characteristics and delays in diagnosis of the lymphoma of sinonasal cavities].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2026
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Artificial intelligence-based differential diagnosis of orbital MALT lymphoma and IgG4 related ophthalmic disease using hematoxylin-eosin images.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 3 countries.

Hiroaki Miyoshi *Department of Pathology, Kurume University School of Medicine, Kurume, Japan. miyoshi_hiroaki@med.kurume-u.ac.jp.ORCID http://orcid.org/0000-0002-2356-3725
Kensaku Sato *Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
Yoshinori Kabeya *Healthcare Analytics, Global Business Services, IBM Japan Ltd, Tokyo, Japan.
Sho YonezawaHealthcare Analytics, Global Business Services, IBM Japan Ltd, Tokyo, Japan.
Hiroki NakanoHealthcare Analytics, Global Business Services, IBM Japan Ltd, Tokyo, Japan.
Yusuke TakeuchiWatson Health, IBM Corporation, New York, NY, USA.
Issei OzawaHealthcare Analytics, Global Business Services, IBM Japan Ltd, Tokyo, Japan.
Shoichi HigoScience & Technology Intelligence Dpt., Chugai Pharmaceutical Co., Ltd, Tokyo, Japan.
Eriko YanagidaDepartment of Pathology, Kurume University School of Medicine, Kurume, Japan.
Kyohei YamadaDepartment of Pathology, Kurume University School of Medicine, Kurume, Japan.
Kei KohnoDepartment of Pathology, Kurume University School of Medicine, Kurume, Japan.
Takuya FurutaDepartment of Pathology, Kurume University School of Medicine, Kurume, Japan.
Hiroko MutaDepartment of Pathology, Kurume University School of Medicine, Kurume, Japan.
Mai TakeuchiDepartment of Pathology, Kurume University School of Medicine, Kurume, Japan.
Yuya SasakiDepartment of Pathology, Kurume University School of Medicine, Kurume, Japan.
Takuro YoshimuraDepartment of Pathology, Kurume University School of Medicine, Kurume, Japan.
Kotaro MatsudaDepartment of Pathology, Kurume University School of Medicine, Kurume, Japan.
Reiji MutoDepartment of Pathology, Kurume University School of Medicine, Kurume, Japan.
Mayuko MoritsuboDepartment of Pathology, Kurume University School of Medicine, Kurume, Japan.
Kanako InoueDepartment of Pathology, Kurume University School of Medicine, Kurume, Japan.
Takaharu SuzukiDepartment of Pathology, Kurume University School of Medicine, Kurume, Japan.
Hiroaki SekinagaOncology Life Cycle Management Dpt., Chugai Pharmaceutical Co., Ltd, Tokyo, Japan.
Koichi OhshimaDepartment of Pathology, Kurume University School of Medicine, Kurume, Japan.
Kurume University · JPGlobal Services (Slovakia) · SKChugai Pharma (United States) · USIBM (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A pathological evaluation is one of the most important methods for the diagnosis of malignant lymphoma. A standardized diagnosis is occasionally difficult to achieve even by experienced hematopathologists. Therefore, established procedures including a computer-aided diagnosis are desired. This study aims to classify histopathological images of malignant lymphomas through deep learning, which is a computer algorithm and type of artificial intelligence (AI) technology. We prepared hematoxylin and eosin (H&E) slides of a lesion area from 388 sections, namely, 259 with diffuse large B-cell lymphoma, 89 with follicular lymphoma, and 40 with reactive lymphoid hyperplasia, and created whole slide images (WSIs) using a whole slide system. WSI was annotated in the lesion area by experienced hematopathologists. Image patches were cropped from the WSI to train and evaluate the classifiers. Image patches at magnifications of ×5, ×20, and ×40 were randomly divided into a test set and a training and evaluation set. The classifier was assessed using the test set through a cross-validation after training. The classifier achieved the highest levels of accuracy of 94.0%, 93.0%, and 92.0% for image patches with magnifications of ×5, ×20, and ×40, respectively, in comparison to diffuse large B-cell lymphoma, follicular lymphoma, and reactive lymphoid hyperplasia. Comparing the diagnostic accuracies between the proposed classifier and seven pathologists, including experienced hematopathologists, using the test set made up of image patches with magnifications of ×5, ×20, and ×40, the best accuracy demonstrated by the classifier was 97.0%, whereas the average accuracy achieved by the pathologists using WSIs was 76.0%, with the highest accuracy reaching 83.3%. In conclusion, the neural classifier can outperform pathologists in a morphological evaluation. These results suggest that the AI system can potentially support the diagnosis of malignant lymphoma.

Indexed as

Deep LearningAlgorithmsDiagnosis, Computer-AssistedHistological TechniquesHumansImage Interpretation, Computer-AssistedLymphomaLymphoma, FollicularLymphoma, Large B-Cell, DiffuseNeural Networks, ComputerObserver VariationPathologistsPseudolymphoma

Identifiers

PMID32472096
OpenAlexW3032044812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.